Skip to content
Search

Latest Stories

Calls for prescription charges to be scrapped altogether during Covid-19 crisis

Professional bodies representing doctors and pharmacists have asked the government to scrap prescription charges in England during the coronavirus crisis.

In a joint letter to Health Secretary Matt Hancock, Pharmaceutical Services Negotiating Committee, British Medical Association and Dispensing Doctors’ Association have argued that an increased level of risk would always remain for both dispensers and patients as long as patients were required to sign and pay for their prescriptions.


The three bodies recommend “the introduction of temporary removal of the prescription charge altogether” so as “to allow for a smoother and safer prescription for all.”

The letter further states: "We understand that the Government intends to extend the validity period for exemption certificates for low income, maternity and medical exemptions to ensure that already vulnerable patients in these categories will not need a renewed exemption certificate and can use their existing certificate.”

The bodies agree that this would reduce the chances of infection and workload.

They have also asked for “a temporary suspension of the need for a signature when collecting controlled drugs from a dispenser” and hope “unnecessary bureaucracy” such as signing a declaration on the prescription form or EPS token is reduced.

“This is an unnecessary process generating both additional work and cost for both patient and dispenser and we recommend removing the process permanently.”

The charges only apply to patients in England as prescriptions are free in the other three nations of the UK.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less